Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Phase III Study Comparing One Course of Adjuvant Bleomycin, Etoposide and Cisplatin (BEP) and One Course of Carboplatin AUC7 in Clinical Stage I Seminomatous Testicular Cancer

NCT02341989 is registered in ClinicalTrials.gov with St. Olavs Hospital as lead sponsor.

NCT NCT02341989
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02341989 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Phase III Study Comparing One Course of Adjuvant Bleomycin, Etoposide and Cisplatin (BEP) and One Course of Carboplatin AUC7 in Clinical Stage I Seminomatous Testicular Cancer
Lead sponsor
St. Olavs Hospital
Phase
Phase 3
Overall status
Active, not recruiting
Start date
April 8, 2015
Completion date
May 31, 2032
Enrollment
348 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

seminoma, testicular neoplasms